Contact SRI Biosciences

Safety/Toxicology Studies

• Early assessment of possible safety problems guides selection of the most promising product components, avoids costly long-term regulatory delays, and assures effective use of R&D funds. Unreliable data or late regulatory submissions can lead to costly delays in market entry and a loss of competitive market position.
  
  
• SRI's experienced scientists can compile complete toxicological and carcinogenic profiles for your drug substance or vaccine in a timely manner.
  
  
• Our safety evaluation services include the complete range of in-vitro and in-vivo non-clinical laboratory tests needed for regulatory approval. We offer a complete package of safety studies using proved protocols, methods and procedures that have stood the test of agency review. We offer these services:
  
  
• Mammalian toxicology
• Genetic toxicology
• Immunotoxicology
• Microbiology
• Pharmacokinetics and metabolism
• Radiation toxicology




• To aid all the studies, we have developed strong capabilities in
  
  
• Analytical method development
• Dose verification
• Bioanalytical methods development




• Our experienced team, including Diplomats of the American Board Toxicology and the American College of Veterinary Pathology, can provide the level of expertise needed to evaluate your drug compound, vaccine or medical device. Whether you need fast, focused solutions or want to investigate novel approaches within various research areas, SRI delivers the formula for success that will move your product efficiently through development.

Contact Us
     Last Updated Jan 25, 2010